Click for best price
Hepatitis B Therapeutics Market Size, Share 2023
| Market size in 2022 |
US$ 2563.9 million
|
Forecast Market size by 2029 |
US$ 3125.7 million
|
| Growth Rate |
CAGR of 2.9% |
Number of Pages |
62 Pages |
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Therapeutics. This report contains market size and forecasts of Hepatitis B Therapeutics in global, including the following market information:
Global Hepatitis B Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hepatitis B Therapeutics market was valued at US$ 2563.9 million in 2022 and is projected to reach US$ 3125.7 million by 2029, at a CAGR of 2.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Hepatitis B Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hepatitis B Therapeutics include GlaxoSmithKline, Bristol-Myers Squibb, Novira Therapeutics, Johnson & Johnson, Abivax, F. Hoffmann- La Roche, Novartis and Merck, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis B Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hepatitis B Therapeutics Market Segment Percentages, by Type, 2022 (%)
Hepatitis B Vaccine
Anti-viral Drugs
Global Hepatitis B Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hepatitis B Therapeutics Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Hepatitis B Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hepatitis B Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hepatitis B Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Bristol-Myers Squibb
Novira Therapeutics
Johnson & Johnson
Abivax
F. Hoffmann- La Roche
Novartis
Merck
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatitis B Therapeutics, market overview.
Chapter 2: Global Hepatitis B Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Hepatitis B Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatitis B Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Hepatitis B Therapeutics Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 2563.9 million
|
| Forecast Market size by 2029 |
US$ 3125.7 million
|
| Growth Rate |
CAGR of 2.9% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hepatitis B Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis B Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis B Therapeutics Overall Market Size
2.1 Global Hepatitis B Therapeutics Market Size: 2022 VS 2029
2.2 Global Hepatitis B Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hepatitis B Therapeutics Players in Global Market
3.2 Top Global Hepatitis B Therapeutics Companies Ranked by Revenue
3.3 Global Hepatitis B Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Hepatitis B Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hepatitis B Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatitis B Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Hepatitis B Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Hepatitis B Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hepatitis B Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Hepatitis B Vaccine
4.1.3 Anti-viral Drugs
4.2 By Type - Global Hepatitis B Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Hepatitis B Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Hepatitis B Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Hepatitis B Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis B Therapeutics Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Hepatitis B Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Hepatitis B Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Hepatitis B Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Hepatitis B Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Hepatitis B Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Hepatitis B Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Hepatitis B Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Hepatitis B Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Hepatitis B Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Hepatitis B Therapeutics Revenue, 2018-2029
6.3.2 US Hepatitis B Therapeutics Market Size, 2018-2029
6.3.3 Canada Hepatitis B Therapeutics Market Size, 2018-2029
6.3.4 Mexico Hepatitis B Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Hepatitis B Therapeutics Revenue, 2018-2029
6.4.2 Germany Hepatitis B Therapeutics Market Size, 2018-2029
6.4.3 France Hepatitis B Therapeutics Market Size, 2018-2029
6.4.4 U.K. Hepatitis B Therapeutics Market Size, 2018-2029
6.4.5 Italy Hepatitis B Therapeutics Market Size, 2018-2029
6.4.6 Russia Hepatitis B Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Hepatitis B Therapeutics Market Size, 2018-2029
6.4.8 Benelux Hepatitis B Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Hepatitis B Therapeutics Revenue, 2018-2029
6.5.2 China Hepatitis B Therapeutics Market Size, 2018-2029
6.5.3 Japan Hepatitis B Therapeutics Market Size, 2018-2029
6.5.4 South Korea Hepatitis B Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Hepatitis B Therapeutics Market Size, 2018-2029
6.5.6 India Hepatitis B Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Hepatitis B Therapeutics Revenue, 2018-2029
6.6.2 Brazil Hepatitis B Therapeutics Market Size, 2018-2029
6.6.3 Argentina Hepatitis B Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hepatitis B Therapeutics Revenue, 2018-2029
6.7.2 Turkey Hepatitis B Therapeutics Market Size, 2018-2029
6.7.3 Israel Hepatitis B Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Hepatitis B Therapeutics Market Size, 2018-2029
6.7.5 UAE Hepatitis B Therapeutics Market Size, 2018-2029
7 Hepatitis B Therapeutics Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Hepatitis B Therapeutics Major Product Offerings
7.1.4 GlaxoSmithKline Hepatitis B Therapeutics Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Company Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Hepatitis B Therapeutics Major Product Offerings
7.2.4 Bristol-Myers Squibb Hepatitis B Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Bristol-Myers Squibb Key News & Latest Developments
7.3 Novira Therapeutics
7.3.1 Novira Therapeutics Company Summary
7.3.2 Novira Therapeutics Business Overview
7.3.3 Novira Therapeutics Hepatitis B Therapeutics Major Product Offerings
7.3.4 Novira Therapeutics Hepatitis B Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Novira Therapeutics Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Hepatitis B Therapeutics Major Product Offerings
7.4.4 Johnson & Johnson Hepatitis B Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Abivax
7.5.1 Abivax Company Summary
7.5.2 Abivax Business Overview
7.5.3 Abivax Hepatitis B Therapeutics Major Product Offerings
7.5.4 Abivax Hepatitis B Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Abivax Key News & Latest Developments
7.6 F. Hoffmann- La Roche
7.6.1 F. Hoffmann- La Roche Company Summary
7.6.2 F. Hoffmann- La Roche Business Overview
7.6.3 F. Hoffmann- La Roche Hepatitis B Therapeutics Major Product Offerings
7.6.4 F. Hoffmann- La Roche Hepatitis B Therapeutics Revenue in Global Market (2018-2023)
7.6.5 F. Hoffmann- La Roche Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Hepatitis B Therapeutics Major Product Offerings
7.7.4 Novartis Hepatitis B Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Hepatitis B Therapeutics Major Product Offerings
7.8.4 Merck Hepatitis B Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Merck Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hepatitis B Therapeutics Market Opportunities & Trends in Global Market
Table 2. Hepatitis B Therapeutics Market Drivers in Global Market
Table 3. Hepatitis B Therapeutics Market Restraints in Global Market
Table 4. Key Players of Hepatitis B Therapeutics in Global Market
Table 5. Top Hepatitis B Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hepatitis B Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hepatitis B Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hepatitis B Therapeutics Product Type
Table 9. List of Global Tier 1 Hepatitis B Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis B Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hepatitis B Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Hepatitis B Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hepatitis B Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Hepatitis B Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Hepatitis B Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hepatitis B Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Hepatitis B Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Hepatitis B Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hepatitis B Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hepatitis B Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hepatitis B Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hepatitis B Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hepatitis B Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hepatitis B Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. GlaxoSmithKline Company Summary
Table 31. GlaxoSmithKline Hepatitis B Therapeutics Product Offerings
Table 32. GlaxoSmithKline Hepatitis B Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. GlaxoSmithKline Key News & Latest Developments
Table 34. Bristol-Myers Squibb Company Summary
Table 35. Bristol-Myers Squibb Hepatitis B Therapeutics Product Offerings
Table 36. Bristol-Myers Squibb Hepatitis B Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Bristol-Myers Squibb Key News & Latest Developments
Table 38. Novira Therapeutics Company Summary
Table 39. Novira Therapeutics Hepatitis B Therapeutics Product Offerings
Table 40. Novira Therapeutics Hepatitis B Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Novira Therapeutics Key News & Latest Developments
Table 42. Johnson & Johnson Company Summary
Table 43. Johnson & Johnson Hepatitis B Therapeutics Product Offerings
Table 44. Johnson & Johnson Hepatitis B Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Johnson & Johnson Key News & Latest Developments
Table 46. Abivax Company Summary
Table 47. Abivax Hepatitis B Therapeutics Product Offerings
Table 48. Abivax Hepatitis B Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Abivax Key News & Latest Developments
Table 50. F. Hoffmann- La Roche Company Summary
Table 51. F. Hoffmann- La Roche Hepatitis B Therapeutics Product Offerings
Table 52. F. Hoffmann- La Roche Hepatitis B Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. F. Hoffmann- La Roche Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Hepatitis B Therapeutics Product Offerings
Table 56. Novartis Hepatitis B Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Hepatitis B Therapeutics Product Offerings
Table 60. Merck Hepatitis B Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Merck Key News & Latest Developments
List of Figures
Figure 1. Hepatitis B Therapeutics Segment by Type in 2022
Figure 2. Hepatitis B Therapeutics Segment by Application in 2022
Figure 3. Global Hepatitis B Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hepatitis B Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hepatitis B Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatitis B Therapeutics Revenue in 2022
Figure 8. By Type - Global Hepatitis B Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Hepatitis B Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Hepatitis B Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Hepatitis B Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Hepatitis B Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Hepatitis B Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Hepatitis B Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Hepatitis B Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Hepatitis B Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Hepatitis B Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Hepatitis B Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Hepatitis B Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Hepatitis B Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. GlaxoSmithKline Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bristol-Myers Squibb Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novira Therapeutics Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson & Johnson Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Abivax Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. F. Hoffmann- La Roche Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Merck Hepatitis B Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
